- Home
- GELS vs GPAT Comparison
GELS vs GPAT Comparison
Compare GELS & GPAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GELS
- GPAT
- Stock Information
- Founded
- GELS 2018
- GPAT 2020
- Country
- GELS Australia
- GPAT United States
- Employees
- GELS N/A
- GPAT N/A
- Industry
- GELS
- GPAT
- Sector
- GELS
- GPAT
- Exchange
- GELS NYSE
- GPAT NYSE
- Market Cap
- GELS 15.9M
- GPAT 379.9M
- IPO Year
- GELS 2024
- GPAT 2024
- Fundamental
- Price
- GELS $1.81
- GPAT $10.53
- Analyst Decision
- GELS
- GPAT
- Analyst Count
- GELS 0
- GPAT 0
- Target Price
- GELS N/A
- GPAT N/A
- AVG Volume (30 Days)
- GELS 232.4K
- GPAT 51.6K
- Earning Date
- GELS 02-15-2025
- GPAT 01-01-0001
- Dividend Yield
- GELS N/A
- GPAT N/A
- EPS Growth
- GELS N/A
- GPAT N/A
- EPS
- GELS N/A
- GPAT 0.36
- Revenue
- GELS $233,830.00
- GPAT N/A
- Revenue This Year
- GELS N/A
- GPAT N/A
- Revenue Next Year
- GELS N/A
- GPAT N/A
- P/E Ratio
- GELS N/A
- GPAT $29.50
- Revenue Growth
- GELS 10.19
- GPAT N/A
- 52 Week Low
- GELS $0.77
- GPAT $9.99
- 52 Week High
- GELS $5.50
- GPAT $10.64
- Technical
- Relative Strength Index (RSI)
- GELS N/A
- GPAT N/A
- Support Level
- GELS N/A
- GPAT N/A
- Resistance Level
- GELS N/A
- GPAT N/A
- Average True Range (ATR)
- GELS 0.00
- GPAT 0.00
- MACD
- GELS 0.00
- GPAT 0.00
- Stochastic Oscillator
- GELS 0.00
- GPAT 0.00
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.
About GPAT GP-ACT III ACQUISITION CORP
GP-Act III Acquisition Corp is a blank check company.